This is the content of the pop-over!





HESI Mental Health NP (HesiMentalHealth) Practice Tests & Test Prep by Exam Edge - Free Test


Our free HESI Psychiatric Mental Health NP (HesiMentalHealth) Practice Test was created by experienced educators who designed them to align with the official Health Education Systems, Inc content guidelines. They were built to accurately mirror the real exam's structure, coverage of topics, difficulty, and types of questions.

Upon completing your free practice test, it will be instantly reviewed to give you an idea of your score and potential performance on the actual test. Carefully study your feedback to each question to assess whether your responses were correct or incorrect. This is an effective way to highlight your strengths and weaknesses across different content areas, guiding you on where to concentrate your study efforts for improvement on future tests. Our detailed explanations will provide the information you need to enhance your understanding of the exam content and help you build your knowledge base leading you to better test results.

Login or Create an Account to take a free test

After you have completed your free test you will receive a special promo code that will save your between 10-15% on any additional practice tests!


** Sample images, content may not apply to your exam **


Additional test information
Back To General Exam Info

HESI Psychiatric Mental Health NP - Free Test Sample Questions

What is the risk of taking Dantrium?





Correct Answer:
hepatoxicity


dantrium, also known by its generic name dantrolene, is primarily used as a muscle relaxant to treat conditions such as muscle spasticity and malignant hyperthermia, a serious reaction to certain drugs used for anesthesia. while dantrium can be effective in these scenarios, one of its significant risks is hepatoxicity, which refers to liver damage caused by chemicals.

hepatoxicity associated with dantrium can range from mild liver enzyme elevations to severe liver damage, including hepatitis and, in rare cases, fatal fulminant hepatic failure. the risk of developing liver toxicity from dantrium is higher in certain populations, such as females, older adults, and those using the medication for prolonged periods. due to these risks, it is essential that the liver function of patients taking dantrium is monitored regularly through blood tests.

the medication is specifically contraindicated in patients with pre-existing liver diseases, as their condition can exacerbate the effects of hepatoxicity. the initial symptoms of liver damage can be non-specific and include nausea, malaise, fatigue, and jaundice. if any of these symptoms are observed, it is crucial to assess liver function immediately and consider discontinuing the drug if significant liver injury is suspected.

in summary, while dantrium is an effective treatment for certain muscular and neurological conditions, its use carries a considerable risk of hepatoxicity, particularly in vulnerable populations. this risk necessitates careful patient selection, regular monitoring, and immediate action if symptoms of liver damage occur. always consult healthcare providers for a thorough risk assessment and monitoring plan when prescribed dantrium.